NPR February 29, 2024
Rob Stein

NEAR BLACKSBURG, Va. — It’s a crisp, clear winter day as I drive down a winding two-lane road through the foothills of the Blue Ridge Mountains in southwest Virginia and turn onto an unmarked gravel driveway.

At the end of the drive, I meet David Ayares, who runs Revivicor Inc., a biotech company based in Blacksburg, Virginia.

Ayares has invited me to be the first journalist to tour the company’s research farm, which is on the forefront of trying to realize a long-sought goal: using cloned farm animals to provide kidneys, hearts, livers and other organs to save thousands of people who need transplants.

“It’s exciting. We’ve been working on this for more than 20 years. And it’s no longer...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
OHSU hospital operating at 100%-plus capacity
Stanford Medicine Children’s Health maintains focus on equity in care
The Rise of Hospice Nurses as Authors, Social Media Influencers
MedPAC estimates $84B in Medicare Advantage overpayments in 2025: 10 notes
Big challenges for health system IT execs in the next 12 months

Share This Article